Learn more about our Advocacy work.
WASHINGTON—AdvaMed, the MedTech Association®, welcomed introduction of the bipartisan Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) by U.S. Sens. Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen…
Washington, D.C.–AdvaMed President and CEO Scott Whitaker released the following statement upon re-introduction of bipartisan legislation aimed at accelerating Medicare coverage for breakthrough medtech and diagnostics. The Ensuring Patient Access…
AtAdvaMed®, we’re proud to be recognized for our work on behalf of the medtech community – and we’re especially grateful when that recognition comes from respected voices like Kwame Ulmer…
Bern/Washington – Swiss Medtech, the leading trade association for medical technology companies in Switzerland, andAdvaMed®, the U.S. Medtech Association and the world’s largest organization representing medtech innovators, are jointly calling…
The U.S. Supreme Court is reviewing Braidwood Management v. Becerra, a high-stakes case challenging the authority of the U.S. Preventive Services Task Force (USPSTF) under the Affordable Care Act. At…
WASHINGTON – Today, President and CEO Scott Whitaker of AdvaMed, the MedTech Association®, testified before the U.S. Senate Committee on Finance in its hearing focused on the impact of tariffs…
A powerful op-ed from AdvaMed’s CEO explaining why tariffs could undermine U.S. medtech innovation, jobs, and patient care—and what must be done.
WASHINGTON—AdvaMed, the MedTech Association®, the world’s largest organization representing medtech innovators, and the Association of British HealthTech Industries (ABHI), the leading trade association for medical technology companies in the United…
AdvaMed® President and CEO Scott Whitaker is leading the call for a reciprocal “zero-for-zero” tariff agreement on medtech, urging the U.S. and its trading partners to eliminate tariffs on essential,…
WASHINGTON – Scott Whitaker, president and CEO of AdvaMed, the MedTech Association®, today called for a reciprocal “zero for zero” model with respect to tariffs among U.S. trading partners for…